| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |